LEAD Coalition submits comments on NIH-wide strategic plan framework

The LEAD Coalition has responded to the five-year NIH strategic plan framework RFI (NOT-OD-26-047). The comments support advancing diverse and representative science, promoting mentorship and training support for early-career investigators, expanding research infrastructure to accelerate equitable real-world advances in AD/ADRD, along with other priorities. Read the comments here.

LEAD Coalition submits FY2027 Appropriations letter to Congress

The LEAD Coalition has submitted its FY2027 appropriations letter to Congress. The letter, signed by 475 LEAD Coalition member organizations and allies, urges Congress to reassert our country’s non-partisan national priority to overcome Alzheimer’s disease and related disorders (AD/ADRD) by making robust appropriations for federal agencies and ensuring complete and timely expenditure of those funds […]

LEAD Coalition Supports Passage of the ASAP Act

On March 9, the LEAD Coalition (Leaders Engaged on Alzheimer’s Disease), the Alzheimer’s Association, and the Alzheimer’s Impact Movement (AIM) – along with 451 signatories – wrote to Congress in support of the bipartisan Alzheimer’s Screening and Prevention (ASAP) Act (H.R. 6130 / S.3267). The ASAP Act would authorize the Secretary of Health and Human Services to allow […]